Delivery Order SPE2DX22D0049-SPE2D826FA2AR

The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $3,333.30 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on December 1, 2025, with completion scheduled for December 2, 2025. This competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The contract will be performed at the company's corporate office in Conshohocken, Pennsylvania, and carries no set-aside designation.

AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement through its extensive portfolio of pharmaceutical products and medical supplies. The company's federal contracting demonstrates capabilities across multiple therapeutic domains, including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities that support military and veteran healthcare systems. This delivery order represents one of numerous transactions under the broader pharmaceutical prime vendor vehicle, which enables AmerisourceBergen to supply essential medical commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems on a global basis.